Financial Ratios

PARNAX LAB LTD.

NSE : NABSE : 506128ISIN CODE : INE383L01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE139.002.9 (+2.13 %)
PREV CLOSE ( ) 136.10
OPEN PRICE ( ) 142.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13357
TODAY'S LOW / HIGH ( )138.00 142.90
52 WK LOW / HIGH ( ) 55167.9
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.050.55-1.33-2.36-0.97
   CEPS(Rs)1.110.60-1.28-2.31-0.92
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)16.8511.145.546.859.20
   Tax Rate(%)25.9630.569.68-324.66-62.75
Margin Ratios
   Core EBITDA Margin(%)21.0519.14-19.346.961.66
   EBIT Margin(%)25.1020.77-17.8511.808.80
   Pre Tax Margin(%)21.7710.91-52.83-6.15-7.83
   PAT Margin (%)16.127.57-47.72-26.10-12.74
   Cash Profit Margin (%)17.038.20-45.87-25.53-12.00
Performance Ratios
   ROA(%)5.582.79-6.68-11.32-4.35
   ROE(%)7.956.92-21.49-29.37-10.04
   ROCE(%)8.857.80-2.575.042.85
   Asset Turnover(x)0.350.370.140.430.34
   Sales/Fixed Asset(x)8.308.172.718.787.42
   Working Capital/Sales(x)1.61-4.85-0.26-1.122.26
Efficiency Ratios
   Fixed Capital/Sales(x)0.120.120.370.110.13
   Receivable days71.7758.50191.94108.52184.05
   Inventory Days33.4735.0956.1713.5023.18
   Payable days82.89123.22273.0581.01124.17
Valuation Parameters
   PER(x)49.64238.620.000.000.00
   PCE(x)46.99220.43-15.24-5.26-36.79
   Price/Book(x)3.0911.823.521.773.66
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)7.9718.7511.752.776.22
   EV/Core EBITDA(x)30.6587.63-73.4422.3665.22
   EV/EBIT(x)31.7690.27-65.8223.4470.75
   EV/CE(x)2.885.971.711.212.27
   M Cap / Sales8.0018.076.991.344.41
Growth Ratio
   Net Sales Growth(%)4.53201.33-69.1018.2811.88
   Core EBITDA Growth(%)27.05502.92-139.9553.39181.61
   EBIT Growth(%)26.31450.57-146.7358.71147.59
   PAT Growth(%)122.46147.8243.51-142.2565.52
   EPS Growth(%)90.10141.4443.51-142.2565.52
Financial Stability Ratios
   Total Debt/Equity(x)0.060.842.421.901.44
   Current Ratio(x)3.530.850.180.321.68
   Quick Ratio(x)3.210.760.120.301.58
   Interest Cover(x)7.532.11-0.510.660.53
   Total Debt/Mcap(x)0.020.070.691.070.39

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.